A Study in Healthy People to See How Zongertinib is Taken up Into the Blood When Given as Tablets Made by Two Different Manufacturers
Clinical trial NCT06360081 · COMPLETED
Trial details
- NCT number
- NCT06360081
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2024-06-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.